Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

der(9;18)(p10;q10)

Identity

 
  +9,der(9; 18)(p10;q10) (G-banding).

Clinics and Pathology

Disease BCR-ABL negative chronic myeloproliferative disorders (CMPD).
Epidemiology Occasional occurrence: 5 cases of polycythemia vera (PV) and one case of therapy associated AML (t-AML) after ET were reported so far.
Clinics 2/5 PV cases showed conversion of PV to post-polycythemic myelofibrosis.
Prognosis Probably associated with progression or leukemic transformation of the CMPD.

Cytogenetics

Cytogenetics Morphological Unbalanced translocation between chromosomes 9 and 18 leading to trisomy of 9p and monosomy of 18p.
 
  +9,der(9;18)(p10;q10) (chromosome painting, WCP#9 (red) + WCP#18 (green)).
Additional anomalies Sole abnormality in most cases; balanced translocations or complex aberrant karyotypes were reported as additional abnormalities.

Genes involved and Proteins

Note Genes involved are unknown. Gain of 9p might play a role for gain of function of the JAK2 gene on 9p24 which codes for the JAK2 nonreceptor kinase.

To be noted

Additional cases are needed to delineate the epidemiology of this rare entity:
you are welcome to submit a paper to our new Case Report section.
Case Report Unbalanced rearrangement der(9;18)(p10;q10) in a patient with polycythemia vera
Case Report Unbalanced rearrangement, der(9;18)(p10;q10) in a patient with myeloproliferative neoplasm. Case 0001M.
Case Report Unbalanced rearrangement, der(9;18)(p10;q10) in a patient with myelodysplastic syndrome. Case 0002M.
Case Report Unbalanced rearrangement der(9;18)(p10;q10) and JAK2 V617F mutation in a patient with AML following post-polycythemic myelofibrosis

Bibliography

Gain of 9p in the pathogenesis of polycythemia vera.
Chen Z, Notohamiprodjo M, Guan XY, Paietta E, Blackwell S, Stout K, Turner A, Richkind K, Trent JM, Lamb A, Sandberg AA
Genes, chromosomes & cancer. 1998 ; 22 (4) : 321-324.
PMID 9669670
 
Karyotypic abnormalities in myelofibrosis following polycythemia vera.
Andrieux J, Demory JL, Caulier MT, Agape P, Wetterwald M, Bauters F, LaˆØ JL
Cancer genetics and cytogenetics. 2003 ; 140 (2) : 118-123.
PMID 12645649
 
Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders.
Bacher U, Haferlach T, Schoch C
Cancer genetics and cytogenetics. 2005 ; 160 (2) : 179-183.
PMID 15993276
 
A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC
The New England journal of medicine. 2005 ; 352 (17) : 1779-1790.
PMID 15858187
 

Contributor(s)

Written09-2006Ulrike Bacher, Claudia Haferlach
Department for Internal Medicine III, Klinikum Grosshadern, Ludwig-Maximilians-University, Marchioninistr. 15, D-81377 Munich, Germany

Citation

This paper should be referenced as such :
Bacher U, Haferlach C . der(9;18)(p10;q10). Atlas Genet Cytogenet Oncol Haematol. Septem ber 2006 .
URL : http://AtlasGeneticsOncology.org/Anomalies/der918p10q10ID1418.html

This paper is referenced by INIST as such :
http://documents.irevues.inist.fr/bitstream/2042/38384/1/09-2006-der918p10q10ID1418.pdf   [ Bibliographic record ]

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Sat Mar 9 12:36:17 CET 2013

Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.